Semaglutide in Youth With Autism Spectrum Disorder
Semaglutide in Youth With Autism Spectrum Disorder
Not yet recruiting · NCT07770152 · Registry updated 2026-08-18Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Semaglutide in Youth With Autism Spectrum Disorder | Body Weight, Nutritional and Metabolic Diseases, Overweight, Pathological Conditions, Signs and Symptoms, Signs and Symptoms, autism spectrum disorder, neurodevelopmental disorder, nutritional disorder, obesity disorder, overnutrition, pervasive developmental disorder, psychiatric disorder | Not yet recruiting | Phase 4 | 2026-08-18 | NCT07770152 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Children's Hospital Medical Center, Cincinnati | 229 |
1 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Cincinnati Children's Hospital Medical Center | Cincinnati | United States | 1 |